Organon Settles Nexplanon Patent-Royalties Suit on Eve of Trial

Organon & Co. and a patent-holding company backed by litigation funders settled a long-pending federal lawsuit over patent royalties for the contraceptive implant Nexplanon, scuttling a jury trial that had been set to begin Monday.

Microspherix LLC and the co-defendants told Judge Renée Marie Bumb during a five-minute video status conference on Oct. 13 that they had reached an agreement to resolve the dispute in the US District Court for the District of New Jersey. Bumb issued an order later that day administratively terminating the case for 60 days while the parties finalize the confidential terms.

Nexplanon’s US sales were ...